encompassing

Scancell reports Phase 2 data showing strongly improved outcomes in Late-Stage Melanoma with its Immunobody iSCIB1+

July 22, 2025 02:00 ET  | Source: Scancell Holdings Plc SCOPE trial of SCIB1/iSCIB1+ plus standard of care shows excellent…

3 weeks ago

LEBUA AT STATE TOWER NAMED #3 HOTEL IN BANGKOK AND #72 IN THE WORLD BY TRAVEL + LEISURE 2025 WORLD’S BEST AWARDS

BANGKOK, July 8, 2025 /PRNewswire/ -- Travel + Leisure today announces the results of its annual World's Best Awards recognizing lebua…

1 month ago